Big Cypress Acquisition Corp

NASDAQ:BCYP   3:52:50 PM EDT
9.91
-0.06 (-0.60%)
Exchange Changes, Mergers / Acquisitions, Equity Financing / Related

Sab Biotherapeutics To List On Nasdaq Through Merger With Big Cypress Acquisition Corp

Published: 06/22/2021 10:15 GMT
Big Cypress Acquisition Corp (BCYP) - Sab Biotherapeutics to List on Nasdaq Through Merger With Big Cypress Acquisition Corp.
, Advancing Unique Human Antibody Platform With Demonstrated Utility in Immunotherapy and Rapid Response to Emerging Diseases.
Sab Biotherapeutics - Upon Merger Closing, Combined Company is Expected to Be Listed on Nasdaq.
Sab Biotherapeutics - Upon Closing of Proposed Deal, Combined Co Will Operate As Sab Biotherapeutics,will Continue to Operate Under Sab Management Team.
Sab Biotherapeutics - Upon Closing of Proposed Deal, Big Cypress Acquisition Corp.
's Samuel J. Reich & Jeffrey G. Spragens to Join Co's Board.
Sab Biotherapeutics - Sab Co-founder, Current Executive Chairman, Edward Hamilton, Plans to Transition to Board Observer Role While Remaining Active in Co.
Sab Biotherapeutics - Proposed Transaction Implies an Enterprise Value for Sab, on a Post-merger Basis, of About $325 Million.